韩国日本国产天天看片,久久熟妇人妻午夜寂寞影院

SV40轉(zhuǎn)化的非洲綠猴腎細(xì)胞C 返回列表頁(yè)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品牌

廠商性質(zhì)生產(chǎn)商

所在地

在線詢(xún)價(jià) 加入對(duì)比查看聯(lián)系電話

更新時(shí)間：2025-02-11 18:16:42瀏覽次數(shù)：22次

聯(lián)系我時(shí)，請(qǐng)告知來(lái)自化工儀器網(wǎng)

SV40轉(zhuǎn)化的非洲綠猴腎細(xì)胞COS-7

種屬	猴
別稱(chēng)	Cos-7; COS7; Cos7; CV-1 in Origin Simian-7
組織來(lái)源	腎臟
疾病	轉(zhuǎn)化細(xì)胞系
傳代比例/細(xì)胞消化	1:2傳代，消化2-3分鐘
培養(yǎng)基配置	DMEM培養(yǎng)基；10%胎牛血清；1%雙抗
簡(jiǎn)介	COS-7細(xì)胞源自CV-1細(xì)胞，經(jīng)帶有編碼野生型T抗原的起始失活突變的SV40轉(zhuǎn)染得到
形態(tài)	成纖維細(xì)胞樣
生長(zhǎng)特征	貼壁生長(zhǎng)
倍增時(shí)間	~35-48h
基因表達(dá)	T antigen
培養(yǎng)條件	氣相：空氣，95% ；二氧化碳，5%。溫度：37攝氏度，培養(yǎng)箱濕度為70%-80%。
凍存條件	凍存液：90%FBS ，DMSO 10%, 或使用非程序凍存液：貨號(hào)JY-H040
保藏機(jī)構(gòu)	ATCC; CRL-1651
產(chǎn)品使用	于科學(xué)研究，不可作為動(dòng)物或人類(lèi)疾病的治療產(chǎn)品使用。

Results: The cohort had a mean age of 39 years and included patients with severe polytrauma. Technical success was achieved in 95% of cases, with no intraoperative deaths or need for open surgical conversion. Perioperative complications were minimal, and the reintervention rate was 5.3%. This study evaluates 10 years of clinical experience managing TAI with TEVAR. Long-term follow-up, with a median duration of 29 months, revealed no graft-related complications or secondary interventions. Imaging confirmed sustained graft integrity, and clinical outcomes were favorable.

Conclusion: TEVAR is a reliable and effective treatment for traumatic aortic injuries, offering excellent technical success rates and minimal perioperative and long-term complications. This study highlights TEVARs advantages in managing polytrauma patients and its role as a minimally invasive alternative to open surgery. Additionally, the findings emphasize the need for comprehensive long-term follow-up protocols. Future research should aim to address challenges related to device durability and the integration of advanced imaging techniques to further enhance patient outcomes and broaden the applicability of TEVAR in trauma care.